TY - JOUR
T1 - Obstacles in Early Diagnosis of Children With Juvenile Idiopathic Arthritis
T2 - A Nationwide Israeli Retrospective Study
AU - Frenkel, Yochai
AU - Kraushar, Irit
AU - Saied, Mohamad Hamad
AU - Haviv, Ruby
AU - Uziel, Yosef
AU - Heshin-Bekenstein, Merav
AU - Ling, Eduard
AU - Amarilyo, Gil
AU - Harel, Liora
AU - Tirosh, Irit
AU - Spielman, Shiri
AU - Berkun, Yackov
AU - Aviel, Yonatan Butbul
N1 - Publisher Copyright:
© 2023 The Journal of Rheumatology.
PY - 2023/6/1
Y1 - 2023/6/1
N2 - Objective. Characterization of the stages that patients with juvenile idiopathic arthritis (JIA) pass until they are diagnosed, and analysis of the different causes that lead to a delay in JIA diagnosis in Israel. Methods. This is a retrospective cohort study conducted in 8 pediatric rheumatology centers in Israel. All patients diagnosed with JIA between October 2017 and October 2019 were included in the study. Demographic, clinical, and data regarding the referring physicians were collected from hospital and community medical charts. Results. Of 207 patients included in the study, 201 cases were analyzed, 71.1% of the population were female. Patients, on average, were evaluated during the diagnostic process by 3.1 different physicians. In most cases, they initially met with a pediatrician in the community setting (61.2%), and later, most commonly referred to a rheumatologist by the community pediatrician (27.9%). The median time until diagnosis was 56.0 days (range: 1.0-2451.0 days). Patients diagnosed with polyarticular and spondyloarthritis/enthesitis-related arthritis (SpA/ERA) JIA subtypes had the longest period until diagnosis (median: 115.5 and 112.0 days, respectively). Younger age correlated with a quicker diagnosis, and females were diagnosed earlier compared to males. Fever at presentation significantly shortened the time to diagnosis (P < 0.01), whereas involvement of the small joints/sacroiliac joints significantly lengthened the time (P < 0.05). Conclusion. This is the first nationwide multicenter study that analyzes obstacles in the diagnosis of JIA in Israel. Raising awareness about JIA, especially for patients with SpA/ERA, is crucial in order to avoid delays in diagnosis and treatment.
AB - Objective. Characterization of the stages that patients with juvenile idiopathic arthritis (JIA) pass until they are diagnosed, and analysis of the different causes that lead to a delay in JIA diagnosis in Israel. Methods. This is a retrospective cohort study conducted in 8 pediatric rheumatology centers in Israel. All patients diagnosed with JIA between October 2017 and October 2019 were included in the study. Demographic, clinical, and data regarding the referring physicians were collected from hospital and community medical charts. Results. Of 207 patients included in the study, 201 cases were analyzed, 71.1% of the population were female. Patients, on average, were evaluated during the diagnostic process by 3.1 different physicians. In most cases, they initially met with a pediatrician in the community setting (61.2%), and later, most commonly referred to a rheumatologist by the community pediatrician (27.9%). The median time until diagnosis was 56.0 days (range: 1.0-2451.0 days). Patients diagnosed with polyarticular and spondyloarthritis/enthesitis-related arthritis (SpA/ERA) JIA subtypes had the longest period until diagnosis (median: 115.5 and 112.0 days, respectively). Younger age correlated with a quicker diagnosis, and females were diagnosed earlier compared to males. Fever at presentation significantly shortened the time to diagnosis (P < 0.01), whereas involvement of the small joints/sacroiliac joints significantly lengthened the time (P < 0.05). Conclusion. This is the first nationwide multicenter study that analyzes obstacles in the diagnosis of JIA in Israel. Raising awareness about JIA, especially for patients with SpA/ERA, is crucial in order to avoid delays in diagnosis and treatment.
KW - Israel
KW - delay in diagnosis
KW - juvenile idiopathic arthritis
UR - http://www.scopus.com/inward/record.url?scp=85160968236&partnerID=8YFLogxK
U2 - 10.3899/jrheum.220359
DO - 10.3899/jrheum.220359
M3 - Article
C2 - 36455949
AN - SCOPUS:85160968236
SN - 0315-162X
VL - 50
SP - 799
EP - 803
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 6
ER -